CN110478525B - Self-crosslinking hydrogel with synergistic effect of sugar and enzyme and preparation method thereof - Google Patents

Self-crosslinking hydrogel with synergistic effect of sugar and enzyme and preparation method thereof Download PDF

Info

Publication number
CN110478525B
CN110478525B CN201910684432.1A CN201910684432A CN110478525B CN 110478525 B CN110478525 B CN 110478525B CN 201910684432 A CN201910684432 A CN 201910684432A CN 110478525 B CN110478525 B CN 110478525B
Authority
CN
China
Prior art keywords
hydrogel
solution
preparation
self
carboxymethyl chitosan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201910684432.1A
Other languages
Chinese (zh)
Other versions
CN110478525A (en
Inventor
裴大婷
刘群峰
于珊
周小雁
耿志杰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute Of Health Medicine Guangdong Academy Of Sciences
Institute of Biological and Medical Engineering of Guangdong Academy of Sciences
Original Assignee
GUANGDONG INSTITUTE OF MEDICAL INSTRUMENTS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GUANGDONG INSTITUTE OF MEDICAL INSTRUMENTS filed Critical GUANGDONG INSTITUTE OF MEDICAL INSTRUMENTS
Priority to CN201910684432.1A priority Critical patent/CN110478525B/en
Publication of CN110478525A publication Critical patent/CN110478525A/en
Application granted granted Critical
Publication of CN110478525B publication Critical patent/CN110478525B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028Polypeptides; Proteins; Degradation products thereof
    • A61L26/0047Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061Use of materials characterised by their function or physical properties
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061Use of materials characterised by their function or physical properties
    • A61L26/0066Medicaments; Biocides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061Use of materials characterised by their function or physical properties
    • A61L26/008Hydrogels or hydrocolloids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23Carbohydrates
    • A61L2300/232Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23Carbohydrates
    • A61L2300/236Glycosaminoglycans, e.g. heparin, hyaluronic acid, chondroitin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/254Enzymes, proenzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)

Abstract

The invention discloses a self-crosslinking hydrogel with sugar and enzyme synergistic effect and a preparation method thereof, wherein the preparation method comprises the following steps: mixing carboxymethyl chitosan, glucose oxidase and peroxidase in water, and standing to form self-crosslinking hydrogel. The raw materials are natural and easily available, have good biocompatibility and are nontoxic; the hydrogel preparation method is simple, rapid and mild, is easy to realize industrial production, has low preparation cost, stable character and easy smearing, does not need to add toxic micromolecule cross-linking agent, initiator and catalyst in the preparation process, has mild reaction condition and good biocompatibility. The hydrogel can be used as a novel wet wound dressing, has good transparency, and can visually observe the condition of the wound; does not adhere to wound surface tissues.

Description

Self-crosslinking hydrogel with synergistic effect of sugar and enzyme and preparation method thereof
Technical Field
The invention belongs to the field of biomedical materials, and particularly relates to a self-crosslinking hydrogel with synergistic effect of sugar and enzyme and a preparation method thereof.
Background
The hydrogel is a solid or semisolid material of a polymer network with a three-dimensional space structure, is soft in texture, high in water content, similar to biological organism tissues, good in biocompatibility and applicable to biomedical fields such as a drug controlled release system, a wound dressing, tissue engineering and the like.
The hydrogel synthesis method mainly comprises physical crosslinking and chemical crosslinking. In the chemical crosslinking preparation, some chemical initiators or crosslinking agents which are harmful to human bodies and the environment are required to be added, so that hydrophilic macromolecules are crosslinked by chemical bonds to form a three-dimensional network structure. However, the residual chemical initiator or cross-linking agent is difficult to remove, so that the hydrogel product is difficult to meet the requirements in the fields of medicines, foods and the like, and the uniformity of the structure is difficult to ensure. The physical crosslinking is to form a three-dimensional network by utilizing the electrostatic action among macromolecules, hydrogen bonds, chain entanglement, ionic bonds or microcrystals and the like, and a chemical initiator or a crosslinking agent is not required to be added, so that the hydrogel product has the advantages of purity and less toxic and side effects.
The selection of hydrogel raw materials and the excellent characteristics of natural polymer materials, such as good biocompatibility, wide sources, capability of being regenerated in a large amount, capability of being degraded by bacteria, difficulty in causing white pollution and the like, become research hotspots. Carboxymethyl chitosan is a chitosan derivative with high water solubility, contains a cation (-NH3+) group and an anion (-COO-) group, and is an amphoteric polyelectrolyte. The carboxymethyl chitosan has stronger inhibition effect on bacteria and fungi, can promote wound healing, diminish inflammation and stop bleeding, and is widely applied to the aspects of medical dressings and drug targeting controlled release carriers. Patent CN201410802337.4 mixes carbomer and carboxylation chitosan to generate cross-linking reaction, and carboxylation chitosan neutralizes carbomer acidity, so that molecular chains of carbomer are dispersed and stretched to be in a greatly expanded state for thickening to form gel. The stability and the bacteriostatic effect (Zhuangyuan red, Liu Jing Na, Huang Jia Fu, et al [ J ]. Zhejiang university journal (agricultural and life science edition), 2015,41(2): 147-. In response to the deficiencies of the prior art, the present invention is directed to a self-crosslinking hydrogel having a synergistic effect of a sugar and an enzyme.
Disclosure of Invention
The invention aims to provide a self-crosslinking hydrogel with synergistic action of sugar and enzyme and a preparation method thereof.
In order to achieve the purpose, the technical scheme adopted by the invention is as follows:
a method for preparing a self-crosslinking hydrogel, comprising the steps of:
mixing carboxymethyl chitosan, glucose oxidase and peroxidase in water, and standing to obtain the self-crosslinking hydrogel.
Further, the method comprises the following steps:
dissolving carboxymethyl chitosan in water to obtain solution A; and (3) performing enzymolysis on glucose, glucose oxidase and peroxide in water to obtain a solution B, mixing the solution A and the solution B, and standing to obtain the crosslinked hydrogel.
Further, the method comprises the following steps:
(1) mixing glucose and carboxymethyl chitosan to obtain solution C;
(2) dissolving glucose oxidase and peroxidase in water to obtain solution D;
(3) the solutions C and D were mixed and left to stand to obtain a crosslinked hydrogel.
Further, the peroxidase is at least one of catalase and horseradish peroxidase.
Further, the mass concentration ratio of the glucose to the carboxymethyl chitosan in the step (1) is (0.5-1.7): (0.6-1.8)%.
Further, the mass ratio of the glucose oxidase to the peroxidase in the step (2) is 0.0025-0.0030: 0.0025-0.0030 g.
Further, the mass concentration of the carboxymethyl chitosan in the solution A is 0.6-1.8%; standing for 4-5 min.
Further, the enzyme in the solution B is glucose oxidase and/or peroxidase, and the mass concentration of the enzyme is 0.5-1.7%.
A self-crosslinking hydrogel prepared by the method of any one of the preceding claims, wherein the hydrogel comprises glucose, chitosan, glucose oxidase and peroxidase.
Further, the chitosan is carboxymethyl chitosan; the peroxidase is at least one of catalase and horseradish peroxidase.
Further, the hydrogel comprises the following components in parts by weight: 0.5-1.7% of glucose, 0.6-1.8% of carboxymethyl chitosan, 0.1-1% of glucose oxidase and 0.1-1% of catalase.
And further, standing for 20-25 minutes.
When the inventor carries out early experiments, the hydrogel is formed for too long time, and the experimental result is influenced. It was discovered occasionally later that mixing glucose with the enzyme followed by the carboxymethyl chitosan solution significantly increased the gel formation time of the gel. The compression is carried out from more than ten minutes to several minutes, so that the working efficiency is greatly improved. And no pH regulator is needed to be added additionally, the reaction condition is mild, and the biocompatibility is good.
The Glucose Oxidase (GOD) can catalyze and oxidize glucose into gluconic acid, plays a role in regulating the pH of a system, and does not need to add an additional pH regulator; the byproduct hydrogen peroxide generated by enzyme-catalyzed oxidation of glucose has an inhibiting effect on the activity of enzyme, the response time of hydrogel to the change of glucose concentration in the environment is influenced, catalase (POD) and GOD are jointly fixed in the hydrogel, the POD can catalyze and decompose the hydrogen peroxide to generate oxygen, the oxygen consumed by GOD reaction in the gel is made up, and the activity utilization rate of the enzyme is improved.
The invention has the beneficial effects that:
the self-crosslinking hydrogel with the synergistic effect of the carboxymethyl chitosan and the enzyme does not need to add a crosslinking agent or an initiator with biological/cell toxicity or an additional pH regulator, has mild reaction conditions, good biocompatibility and strong bacteriostatic effect. The raw materials are all green and environment-friendly, the resource is rich, the price is low and the biocompatibility is good.
Drawings
FIG. 1 is a state of the self-crosslinking hydrogel of the present invention before it becomes gel.
FIG. 2 is a state after the self-crosslinking hydrogel of the present invention is gelled.
Detailed Description
A method for preparing a self-crosslinking hydrogel, comprising the steps of:
mixing carboxymethyl chitosan, glucose oxidase and peroxidase in water, and standing to obtain the self-crosslinking hydrogel.
Preferably, the method comprises the following steps:
dissolving carboxymethyl chitosan in water to obtain solution A; and (3) performing enzymolysis on glucose, glucose oxidase and peroxide in water to obtain a solution B, mixing the solution A and the solution B, and standing to obtain the crosslinked hydrogel.
Preferably, the method comprises the following steps:
(1) mixing glucose and carboxymethyl chitosan to obtain solution C;
(2) dissolving glucose oxidase and peroxidase in water to obtain solution D;
(3) the solutions C and D were mixed and left to stand to obtain a crosslinked hydrogel.
Preferably, the peroxidase is at least one of catalase and horseradish peroxidase.
Preferably, the mass concentration ratio of the glucose to the carboxymethyl chitosan in the step (1) is (0.5-1.7): (0.6-1.8)%.
Preferably, the mass ratio of the glucose oxidase to the peroxidase in the step (2) is 0.0025-0.0030: 0.0025-0.0030 g.
Preferably, the mass concentration of the carboxymethyl chitosan in the solution A is 0.6-1.8%; standing for 4-5 min; standing for 4-5 min.
A self-crosslinking hydrogel prepared by the method of any one of the preceding claims, wherein the hydrogel comprises glucose, chitosan, glucose oxidase and peroxidase.
Preferably, the chitosan is carboxymethyl chitosan; the peroxidase is at least one of catalase and horseradish peroxidase.
Preferably, the hydrogel consists of the following components in parts by weight: 0.5-1.7% of glucose, 0.6-1.8% of carboxymethyl chitosan, 0.1-1% of glucose oxidase and 0.1-1% of catalase.
A method for preparing a self-crosslinking hydrogel, comprising the steps of: mixing carboxymethyl chitosan, glucose oxidase and peroxidase in water, and standing to obtain the self-crosslinking hydrogel.
Example 1
Solution A: 1ml 1.8% carboxymethyl chitosan solution
Solution B: 0.1514g glucose, 0.5mL ultrapure water, 0.0025g glucose oxidase, 0.0025g catalase
Gel time: 4 to 5 minutes
The preparation method comprises the following steps: dissolving 1 mL1.8% carboxymethyl chitosan in water to obtain solution A; 0.1514g glucose, 0.0025g glucose oxidase and 0.0025g hydrogen peroxide are enzymolyzed in 0.5mL water to obtain solution B; and mixing the solution A and the solution B, and standing for 4-5 minutes to obtain the crosslinked hydrogel.
Example 2:
solution A: 1ml 1.4% carboxymethyl chitosan solution
Solution B: 0.1514g glucose, 0.5mL ultrapure water, 0.0025g glucose oxidase, 0.0025g catalase
Gel time: 4 to 5 minutes
The preparation method comprises the following steps: dissolving 1 mL1.4% carboxymethyl chitosan in water to obtain solution A; 0.1514g glucose, 0.0025g glucose oxidase and 0.0025g hydrogen peroxide are enzymolyzed in 0.5mL water to obtain solution B; and mixing the solution A and the solution B, and standing for 4-5 minutes to obtain the crosslinked hydrogel.
Example 3:
solution A: 1mL 1% carboxymethyl chitosan solution
Solution B: 0.1514g glucose, 0.5mL ultrapure water, 0.0025g glucose oxidase, 0.0025g catalase
Gel time: 4 to 5 minutes
The preparation method comprises the following steps: dissolving 1mL of 1% carboxymethyl chitosan in water to obtain solution A; 0.1514g glucose, 0.0025g glucose oxidase and 0.0025g hydrogen peroxide are enzymolyzed in 0.5mL water to obtain solution B; and mixing the solution A and the solution B, and standing for 4-5 minutes to obtain the crosslinked hydrogel.
Comparative example 1:
solution A: 0.1514g glucose, 1 mL1.8% carboxymethyl chitosan solution
Solution B: 0.0025g of glucose oxidase, 0.0025g of catalase and 0.3mL of ultrapure water were dissolved
Gel time: 10 to 20 minutes
The preparation method comprises the following steps: (1) 0.1514g glucose and 1ml 1.8% carboxymethyl chitosan are mixed to obtain solution C, 0.0025g glucose oxidase and 0.0025g peroxidase are dissolved in water to obtain solution D; (2) and mixing the solutions C and D, keeping the initial pH value at 6-7, and standing for 10-20 minutes to obtain the hydrogel.
Comparative example 2:
solution A: 0.1514g glucose, 1 mL1.4% carboxymethyl chitosan solution
Solution B: 0.0025g of glucose oxidase, 0.0025g of catalase and 0.5mL of ultrapure water were dissolved
Gel time: 10 to 20 minutes
The preparation method is the same as that of comparative example 1.
Comparative example 3:
solution A: 0.1514g glucose, 1mL 1% carboxymethyl chitosan solution
Solution B: 0.0025g of glucose oxidase, 0.0025g of catalase and 0.3mL of ultrapure water were dissolved
Gel time: 10 to 20 minutes
The preparation method is the same as that of comparative example 1.
The hydrogel of the above example was further tested for its effectiveness.
Gel collapsibility:
after the hydrogel prepared in the example is added into water and soaked for 24 hours, 48 hours and 72 hours, the shape of the gel is basically unchanged by visual observation. The gel did not collapse, only turning yellow in color.
The main key performance indexes are as follows:
appearance: colorless transparent gel, and turns yellow transparent gel after standing for a period of time. FIG. 1 is a state before the hydrogel of the present invention is gelled, and FIG. 2 is a state after the hydrogel is gelled.
Cytotoxicity: the cytotoxic response was less than grade 1.
Sensitization test: no delayed hypersensitivity reaction.
And (3) gelling time: less than 20min and short time.
Bacteriostasis: the composite gel prepared by the invention has stronger antibacterial effect on staphylococcus aureus, escherichia coli and candida albicans, can be used as a wound dressing, and plays roles in protecting and obstructing external bacteria and preventing infection.
And (3) determination of antibacterial activity:
the antibacterial effect of the composite gel on the strains to be detected (staphylococcus aureus, escherichia coli and candida albicans) is determined by adopting an agar diffusion paper sheet method and a colony counting method.
The method comprises the following steps: preparation of a catalyst containing 1X 108Each/mL of the bacterial suspension of the strain to be detected is evenly coated on the surface of a solid nutrient agar medium plate, and each plate is coated with 100 mu L. Under the aseptic condition, the composite gel prepared by the invention is uniformly coated on the surface of a filter paper sheet which is sterilized and dried to be used as a composite gel paper sheet. The prepared composite gel paper sheet (with the sterilized filter paper sheet as a blank control) was attached to the surface of the plate. Placing four pieces of paper on each plate for biological repetition, and culturing at constant temperature of 37 deg.C for 24 timesh. And (3) gradient dilution of the contact surface culture (4-5 gradients of Candida albicans dilution and 5-6 gradients of staphylococcus aureus and Escherichia coli), putting 1mL of diluted bacterial suspension on a flat plate, pouring agar into the flat plate, uniformly mixing, after solidification, inversely putting the flat plate in a 37 ℃ incubator for culture for 24 hours, and calculating the total number of colonies by referring to GB 47892-2016.
The inhibition ratio R/% (total number of blank colonies-total number of gel colonies)/total number of blank colonies × 100.
TABLE 1 bacteriostatic ratio (%) of hydrogel of carboxymethyl chitosan at various concentrations
Figure BDA0002145755610000061
As can be seen from table 1, the hydrogels of example 1 (1.8%), example 2 (1.4%) and example 3 (1%) all have strong bacteriostatic effects on staphylococcus aureus, escherichia coli and candida albicans, wherein the hydrogel bacteriostatic rates of example 1 (1.8%) reach 98%, 95% and 96%, respectively.
In vitro cytotoxicity assay
In vitro cytotoxicity tests were performed on the composite hydrogels prepared in example 1 (1.8%), example 2 (1.4%), and example 3 (1%). The specific test method is as follows:
3T3(L929) cells were passaged more than 2 times and stably grown. After the pancreatin digestion, human cell culture solution is added, and counting is carried out under a microscope after the cell culture solution is uniformly blown. According to the appropriate cell concentration, the cells were diluted to 250000/mL by adding culture solution and then inoculated into 10mL dishes. Rotating to uniformly disperse cells on the surface of the culture dish, placing at 37 ℃ and 5% CO2Culturing in an incubator.
After the cells grew into a monolayer, the original culture solution was aspirated, and 1.2% agar medium and l 0% MEM medium were preheated to 39 ℃ respectively, and then mixed uniformly at a volume ratio of 1:1 and coagulated. The amount of the cell layer to be added is preferably just enough to cover the cell layer. 5mL of 0. l% neutral red staining solution was added to each dish, and the mixture was placed in an incubator and incubated in the dark for 20min, and then the excess staining solution was discarded.
The test sample was gently placed on a solid nutrient agar medium plate, with the sample covering about one-tenth of the cell layer surface. Negative and positive controls were prepared in the same manner, and the dishes were placed in an incubator for further 24 h. After the culture was completed, the outline of the test sample was marked on the bottom of the petri dish, and the sample was removed. The culture dish was placed under a microscope to observe the discoloration of the cell area.
As a result: the results show that the gels of example 1 (1.8%), example 2 (1.4%) and example 3 (1%) had a grade 1 cytotoxicity response.
The above embodiments are preferred embodiments of the present invention, but the present invention is not limited to the above embodiments, and any other changes, modifications, substitutions, combinations, and simplifications which do not depart from the spirit and principle of the present invention should be construed as equivalents thereof, and all such changes, modifications, substitutions, combinations, and simplifications are intended to be included in the scope of the present invention.

Claims (5)

1. A method for preparing a self-crosslinking hydrogel, comprising the steps of:
mixing carboxymethyl chitosan, glucose oxidase and peroxidase in water, and standing to obtain self-crosslinking hydrogel; the steps include: dissolving carboxymethyl chitosan in water to obtain solution A; and (3) performing enzymolysis on glucose, glucose oxidase and peroxide in water to obtain a solution B, mixing the solution A and the solution B, and standing to obtain the crosslinked hydrogel.
2. The method according to claim 1, wherein the peroxidase is at least one of catalase and horseradish peroxidase.
3. The preparation method according to claim 1, wherein the mass concentration of carboxymethyl chitosan in the solution A is 0.6-1.8%; the standing time is 4-5 min.
4. A self-crosslinking hydrogel prepared by the method of any one of claims 1 to 3, wherein the hydrogel comprises glucose, carboxymethyl chitosan, glucose oxidase and peroxidase.
5. The hydrogel of claim 4, wherein the peroxidase is at least one of catalase and horseradish peroxidase.
CN201910684432.1A 2019-07-26 2019-07-26 Self-crosslinking hydrogel with synergistic effect of sugar and enzyme and preparation method thereof Active CN110478525B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910684432.1A CN110478525B (en) 2019-07-26 2019-07-26 Self-crosslinking hydrogel with synergistic effect of sugar and enzyme and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910684432.1A CN110478525B (en) 2019-07-26 2019-07-26 Self-crosslinking hydrogel with synergistic effect of sugar and enzyme and preparation method thereof

Publications (2)

Publication Number Publication Date
CN110478525A CN110478525A (en) 2019-11-22
CN110478525B true CN110478525B (en) 2021-12-07

Family

ID=68548585

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910684432.1A Active CN110478525B (en) 2019-07-26 2019-07-26 Self-crosslinking hydrogel with synergistic effect of sugar and enzyme and preparation method thereof

Country Status (1)

Country Link
CN (1) CN110478525B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114262450B (en) * 2021-12-24 2023-04-25 华中科技大学鄂州工业技术研究院 Antibacterial hydrogel and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104117057A (en) * 2014-07-09 2014-10-29 广东省医疗器械研究所 Loaded enzyme hydrogel composition with oxygen releasing function and hydrogel prepared from hydrogel composition
CN109266638A (en) * 2018-09-30 2019-01-25 江南大学 A kind of preparation method of dynamic key hydrogel and its application in terms of enzyme immobilization
CN110036106A (en) * 2016-10-04 2019-07-19 博洛尼亚大学 For adjusting composition, the device and method of the chemical micro-environment of cell culture in vitro

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11034950B2 (en) * 2017-11-02 2021-06-15 Saint Louis University Delivering enzyme using an injectable hydrogel depot

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104117057A (en) * 2014-07-09 2014-10-29 广东省医疗器械研究所 Loaded enzyme hydrogel composition with oxygen releasing function and hydrogel prepared from hydrogel composition
CN110036106A (en) * 2016-10-04 2019-07-19 博洛尼亚大学 For adjusting composition, the device and method of the chemical micro-environment of cell culture in vitro
CN109266638A (en) * 2018-09-30 2019-01-25 江南大学 A kind of preparation method of dynamic key hydrogel and its application in terms of enzyme immobilization

Also Published As

Publication number Publication date
CN110478525A (en) 2019-11-22

Similar Documents

Publication Publication Date Title
Huq et al. Sources, production and commercial applications of fungal chitosan: A review
CN102702727B (en) Preparation method for antibacterial composite material
WO2022088286A1 (en) Water-soluble controllable antibacterial substance and synthesis process
CN107555607B (en) Biological composite oxygen increasing agent and preparation method thereof
CN111718498B (en) Preparation method and use method of inorganic hybrid self-repairing hydrogel
WO2022247225A1 (en) Symbiotic bacteria composition, preparation method therefor and culture method for microalgae
CN101705099B (en) Composite material used in soil remediation and preparation method thereof
CN104784739B (en) A kind of preparation method for carrying flamazine compound antiseptic dressing
CN110478525B (en) Self-crosslinking hydrogel with synergistic effect of sugar and enzyme and preparation method thereof
CN115227864B (en) Preparation method and application of multifunctional nano-enzyme in-situ hydrogel
CN110152055A (en) The functional drug that alginic acid amination derivative/bacteria cellulose nanocomposite gel is constructed is sustained medical dressing
CN113367157A (en) Preparation method of flower-like silver/lignin composite antibacterial particles
CN112870431B (en) Antibacterial hydrogel with G-quadruplex structure used as cascade reactor and preparation method and application thereof
AU746982B2 (en) Process for preparing a polyvinyl alcohol gel and mechanically highly stable gel produced by this process
CN104694594A (en) Preparation method and application of sea cucumber epiphytic Bacillus subtilis exopolysaccharide
Vijayalakshmi et al. Industrial applications of alginate
KR20100079362A (en) Preparation of low molecular weight hualuronic acid by acid treatment
CN114097788B (en) Fenton-like slow-release antibacterial hydrogel and preparation method and application thereof
CN113214508B (en) Natural antibacterial gel for skin repair and preparation method thereof
CN114796582A (en) Preparation method of bacteriostatic gel containing graphene oxide
CN112791100A (en) Composite antibacterial microsphere with efficient active oxygen scavenging function and preparation method thereof
Nicomrat Silver nanoparticles impregnated biocellulose produced by sweet glutinous rice fermentation with the genus Acetobacter
US20230381325A1 (en) Long-lasting hydrogel for use against drug-resistant bacteria and preparation method and use thereof
CN115025280B (en) Bacterial hydrolase response type hydrogel antibacterial dressing and preparation method thereof
CN116251224B (en) Lactoferrin gel dressing and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CP01 Change in the name or title of a patent holder
CP01 Change in the name or title of a patent holder

Address after: No. 1307, Guangzhou Avenue middle, Tianhe District, Guangzhou, Guangdong 510500

Patentee after: Institute of health medicine, Guangdong Academy of Sciences

Address before: No. 1307, Guangzhou Avenue middle, Tianhe District, Guangzhou, Guangdong 510500

Patentee before: GUANGDONG INSTITUTE OF MEDICAL INSTRUMENTS

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20231129

Address after: No.10, shiliugang Road, Haizhu District, Guangzhou City, Guangdong Province 510000

Patentee after: Institute of biological and medical engineering, Guangdong Academy of Sciences

Address before: No. 1307, Guangzhou Avenue middle, Tianhe District, Guangzhou, Guangdong 510500

Patentee before: Institute of health medicine, Guangdong Academy of Sciences